AMAM

Ambrx Biopharma, Inc. Common Stock

Delisted

AMAM was delisted on the 6th of March, 2024.

0 hedge funds and large institutions have $0 invested in Ambrx Biopharma, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
-68
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
68
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
VF
51
Virtu Financial
New York
-$290K -20,386 Closed
Citigroup
52
Citigroup
New York
-$267K -18,774 Closed
BCM
53
Bayesian Capital Management
New York
-$225K -15,804 Closed
Squarepoint
54
Squarepoint
New York
-$220K -15,470 Closed
OWP
55
Old Well Partners
North Carolina
-$205K -14,400 Closed
EGM
56
Engineers Gate Manager
New York
-$176K -12,388 Closed
JPMorgan Chase & Co
57
JPMorgan Chase & Co
New York
-$175K -12,312 Closed
Tudor Investment Corp
58
Tudor Investment Corp
Connecticut
-$154K -10,800 Closed
MFS
59
Mirabella Financial Services
United Kingdom
-$143K -10,040 Closed
Simplex Trading
60
Simplex Trading
Illinois
-$109K -7,657 Closed
CUAMC
61
China Universal Asset Management Company
China
-$104K -7,303 Closed
VEA
62
Virtus ETF Advisers
New York
-$97.9K -6,878 Closed
TRCT
63
Tower Research Capital (TRC)
New York
-$79.9K -5,614 Closed
UBS Group
64
UBS Group
Switzerland
-$54.7K -3,840 Closed
CG
65
Cutler Group
California
-$33K -2,380 Closed
US Bancorp
66
US Bancorp
Minnesota
-$12.9K -906 Closed
GI
67
GAMMA Investing
California
-$13.7K -491 Closed
Daiwa Securities Group
68
Daiwa Securities Group
Japan
-$4K -258 Closed